Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > News out:Trikoka Gone and
View:
Post by Kingpin68 on Nov 15, 2021 4:47pm

News out:Trikoka Gone and

Dr. Vera Madzarevic, Ph.D. will assume the role of Director of Clinical Development and Quality Assurance
Comment by enriquesuave on Nov 15, 2021 4:54pm
Well looks like they have found the ideal person to run clinical trials and get us moving fast I hope.
Comment by enriquesuave on Nov 15, 2021 5:00pm
I like this girl already. Go Vera! https://www.udemy.com/user/veramadzarevic/
Comment by StevenBirch on Nov 15, 2021 5:09pm
Your endorsement is good enough for me Enrique.  On a side note I went to the first post-Roger AGM, although he was there, with Shawn Shirazi and Kipton Lade and by far the most impressive person that spoke was Dr. Mandel. So I for one am happy with him having a bigger role and if as some have suggested Roger makes a return from the penalty box at some point I am good with that too. Now let ...more  
Comment by Eoganacht on Nov 15, 2021 6:16pm
She looks great.
Comment by DJDawg on Nov 16, 2021 11:30am
I'm impressed that she actually wrote a textbook in this area. "Vera is a published author, with her last work being Clinical Trials Audit Preparation: A Guide for Good Clinical Practice (GCP) Inspections" It seems that she is the kind of person who can be selective about which work she takes. The fact that she signed on here is a good sign.
Comment by CAinPlap on Nov 16, 2021 5:30pm
Big fan of the Vera hire!! A trial professional is more valuable than the CEO position IMO. Wondering how earnestly they were/are searching for a competent CEO as it is my belief that they were/are biding their time until Roger's suspension is up.
Comment by socksnblonds642 on Nov 16, 2021 5:45pm
The question is how many topline CEOs would work for Theralase considering its current SP? They are not going to attract the cream of the crop CEOs. A scientific position however is different. Not only did they look for someone of her stature she accepted the position. They identified they needed to find someone like her and she obviously found the science and current results favorable. To your ...more  
Comment by langosta on Nov 16, 2021 7:10pm
I don't think they would be looking for a top line CEO. These folks have reached the top of the food chain and have no desire to begin again. It is often the case where the ideal candidate is already employed by a big pharma and is frustrated as he/she does not see an opportunity for advancement or express his/her ideas, a small pharma with encouraging science could be ideal for a bright ...more  
Comment by Infinity on Nov 15, 2021 5:07pm
I think this is a good move.  Did not hear a single statement, new srelease from John Trikola in the last couple of months.  What ever "came to light " about John Trikola has little or no significance now.  Hopefully the New Director of Clinical Development with her past experience in the contract research and testing field  will do much better.  She still has Dr ...more  
Comment by Rumpl3StiltSkin on Nov 16, 2021 9:18am
Well, as I understand it he was a bit of a Himbo basck in the late seventies. Spent way too much time at Studio 54, but he was quite a dancer and the ladies liked him. Then there was that awkward highschool phase when he was a member of that gang the 'Sweathogs'. I'm sure all of that was part of the issue.
Comment by socksnblonds642 on Nov 16, 2021 9:23am
ROFL don't forget he also got the chills and they were mulitiplyin....
Comment by socksnblonds642 on Nov 15, 2021 8:27pm
They sure have. To attract someone wit those credentials bodes well for Theralase.
Comment by skys1 on Nov 15, 2021 8:31pm
All positive. IMO, TLT is a stronger compant today than it was a couple weeks ago.
Comment by Pandora on Nov 15, 2021 6:07pm
  Theralase Technologies replaces interim CEO with Mandel   2021-11-15 17:48 ET - News Release   Ms. Kristina Hachey reports THERALASE ANNOUNCES LEADERSHIP REORGANIZATION Theralase Technologies Inc. is making the following leadership changes in a reorganization. Effective Nov. 15, 2021, Dr. Arkady Mandel, MD, PhD, DSc, who is currently the chief scientific officer ...more  
Comment by cleareye on Nov 15, 2021 6:24pm
Some unusual honesty about the ceo who was shown the door. None of the boilerplate, "we wish xxx well in his future xxx". There must be no doubt. The board reaaly wants a clear and clean break. Well, I appreciate their frank announcement. Onwards! cleareye.
Comment by jicoop on Nov 15, 2021 7:41pm
That stype of announcement usually means one of the biggies nowadays : Sexual misconduct , racist background, financial wrongdoing, etc, or could even be anti LGBTQ comments, prior work at Residential schools , former religious affiliations or beliefs , etc . Does not take much these days to be turfed, but I'm sure rightfully so, and for good reason Zero tolerance in this new world . Coop
Comment by O12009 on Nov 15, 2021 8:28pm
Sounds like something he should have revealed in the interview 
Comment by Longholder99 on Nov 15, 2021 9:24pm
I wonder how this came up? Why it came up? They talking to a bigger fish in the pond that prompted a closer look for a down the road relationship issue? Just thinking....corporate governance is a big deal for a large Pharma corp.
Comment by stocksnbonds458 on Nov 15, 2021 9:09pm
I couldn't ever figure out why they hired a guy for the laser division, I considered this as misplaced priorities and a focus in the wrong direction. The fact he is gone (for whatever reason) and the hiring of this extremely qualified scientist indicates they have redirected their priorities where they should be.
Comment by DJDawg on Nov 15, 2021 9:40pm
Like all of you I'm glad to see the change up to more clinical trial experienced people. I have to say, the whole Trikoka thing was weird from the get go. Was I the only one that thought it was strange that the only pic for the ceo was a blurry off centre picture (see the cover of the last newsletter)? Just strange. CEOs usually warrant a high quailty pic. I'm sure we will never know. TLT ...more  
Comment by Oilminerdeluxe on Nov 16, 2021 1:26am
Well, at least we got some action, lol. Not long to go until the Q-report. Hopefully, this dude has not messed up things. I will go loco one of these days.
Comment by woundedknee on Nov 16, 2021 5:32am
Maybe also, he believes that natural immunity is more potent than these vaccines that have a short shelf life, don't protect you from getting reinfected or even from spreading the virus. Heaven forbid someone tells the truth. That person must immediately be fired.
Comment by Kingpin68 on Nov 16, 2021 9:00am
Ya, if he was some yahoo that doesn't believe in science and vaccines, then goodbye. The vaccine keeps most out of ICU, and from dying. I'll take that benefit, thank you Wounded knee
Comment by socksnblonds642 on Nov 16, 2021 9:14am
Random. Something on your mind WK?  Redirect... I agree with the corporate governance idea. This was likely vetted by a potential suitor or partner wether private or government. Likely didn't happen organically but jmo 
Comment by Infinity on Nov 16, 2021 9:28am
Anyway,  I like the fact that we have a team headed by Dr. Mandel who will remain focused on the primary objective that is to Anti Cancer...  I believe TLT will eventually need someone with Medical Device marketing experience to head that part of the business.   TLT will need to make the Laser division profitable and possibly spin it off and concentrate on the Core Business of ...more  
Comment by langosta on Nov 16, 2021 10:29am
So Dr Vera took over  3 weeks ago. Effective October 25, 2021, Dr. Vera Madzarevic, Ph.D. will assume the role of Director of Clinical Development and Quality Assurance reporting to Dr. Mandel. Dr. Vera M. Madzarevic is a published author and Clinical Scientist as well as a clinical research professional with a demonstrated history of effectively working with the pharmaceutical and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250